Bayer Aktiengesellschaft (ETR:BAYN) pharma head Stefan Oelrich told attendees at the 2026 J.P. Morgan Healthcare Conference ...

Drug products for oncology and neurological diseases will be manufactured in a second facility Johnson & Johnson plans to ...

Handler completes year-long process, meeting 275 audit requirements for temperature-sensitive pharmaceutical logistics at MIA ...

Pharmaceutical patent protection can be extended when drug companies bring newer products to market before their first patent ...

Rice remains the most exported commodity but volumes have dipped since 2022; pharmaceutical exports hit five-year high ...

FAYETTEVILLE, NY, UNITED STATES, January 7, 2026 /EINPresswire.com/ — January is traditionally a peak period for ...

Tokyo, Japan and Cambridge, UK, 13 January 2026 - Nxera Pharma Co., Ltd. ('Nxera” or 'the Company”; TSE 4565) notes that ...

So, on a chilly Friday, a meeting was arranged. Ostro cofounders Chase Feiger and Ahmed Elsayyad pitched their hearts out, ...

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

Facing the loss of exclusivity on key products, Pfizer has pulled forward its lead obesity asset into Phase III and targeted ...

With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...